Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Quest Diagnostics    DGX

QUEST DIAGNOSTICS

(DGX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • In a short-term perspective, the company has interesting fundamentals.
Strengths
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The tendency within the weekly time frame is positive above the technical support level at 93.04 USD
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at USD 118.28.
  • The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
  • The group shows a rather high level of debt in proportion to its EBITDA.
  • For the past year, analysts have significantly revised downwards their profit estimates.
Ratings chart
Sector Healthcare Facilities & Services - NEC
1st jan.Capitalisation (M$)Investor Rating
QUEST DIAGNOSTICS6.80%15 518
CVS HEALTH CORPORATION-12.91%84 569
HCA HEALTHCARE, INC.-33.72%33 077
FRESENIUS MEDICAL CARE AG &..19.74%25 999
PING AN HEALTHCARE AND TECH..113.02%16 745
LABORATORY CORPORATION OF A..0.65%16 550
DAVITA INC.7.48%9 872
UNIVERSAL HEALTH SERVICES-34.75%7 950
CHEMED CORPORATION6.40%7 419
WINNING HEALTH TECHNOLOGY G..86.15%6 372
ENCOMPASS HEALTH CORPORATIO..-10.28%6 178
RYMAN HEALTHCARE LIMITED-20.94%4 233
JINXIN FERTILITY GROUP LIMI..18.23%3 912
KORIAN SA-19.51%3 137
BUMRUNGRAD HOSPITAL-18.37%3 094
DIAN DIAGNOSTICS GROUP CO.,..54.54%2 959
More Results
Financials (USD)
Sales 2020 7 647 M - -
Net income 2020 610 M - -
Net Debt 2020 3 495 M - -
P/E ratio 2020 26,1x
Yield 2020 1,92%
Capitalization 15 518 M 15 518 M -
EV / Sales 2019
EV / Sales 2020 2,49x
Nbr of Employees 47 000
Free-Float 61,4%
Upcoming event on QUEST DIAGNOSTICS
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes